Accelerating Canada-Mexico Life Sciences Innovation

Canada and Mexico are accelerating cross-border life sciences trade and technological innovation as diplomatic and commercial leaders seek to build resilient regional supply chains. During a trade mission in Mexico City, representatives from the Embassy of Canada, the Ontario Government, and Pragmatec outlined expanding bilateral initiatives spanning digital health, biomanufacturing, AI, and pharmaceutical infrastructure. 

Amid shifting geopolitical dynamics across North America, Canada and Mexico are expanding commercial partnerships in the life sciences and healthcare sectors. During the Mexico Health Summit 2026, trade officials and industry leaders outlined plans to deepen bilateral integration in digital health, medical technology, and pharmaceutical supply chains.

"In North America, we are navigating a period of change and uncertainty in trade matters, which makes reliable alliances more important than ever," says Dan-Tam Nguyen, Trade Commissioner at the Embassy of Canada in Mexico. "For Canada, Mexico is a key partner."

Bilateral momentum has accelerated through a series of commercial trade missions. In March, a delegation of 150 companies visited Mexico, followed by a Mexican trade mission to Quebec and Toronto in May. The latest initiative brought 12 digital health and medical technology companies from Ontario and other Canadian provinces to Mexico City.

These activities support the broader Canada-Mexico Action Plan 2025–2028. To formalize public-sector collaboration, Innovation, Science and Economic Development Canada signed a memorandum of understanding with Mexico’s Ministry of Economy to advance biomanufacturing, industrial innovation, and resilient health supply chains.

"We are seeing a level of collaboration that was difficult to imagine a few years ago," Nguyen says.

Sectoral Diversification and Commercial Scale

While trade between the two nations has historically centered on the automotive sector, officials are actively pursuing sectoral diversification. The current trade delegation marks the first time Ontario has sent a dedicated life sciences mission to Mexico.

Mexico represents Latin America’s second-largest healthcare market, with the sector accounting for 12% of national gross domestic product. This scale presents significant commercial opportunities alongside infrastructure challenges that digital health solutions can help address.

"When we talk about diversification processes, it refers not only to new destinations but also to new sectors," says José Abad-Puelles, Commercial Counsellor and Head, Ontario Trade and Investment Office. "Access to healthcare must be for everyone, and instruments like digital health can fill that void."

Ontario serves as Canada's primary hub for life sciences. The province generates 60% of national healthcare sector revenues, houses 53% of the industry workforce, and accounts for 62% of Canada’s health-related exports.

Abad-Puelles notes that Ontario's health ecosystem spans physical and digital AI, services for aging populations, and specialized infrastructure. The province operates nuclear research reactors dedicated specifically to cancer research and treatment development.

Building Long-Term Bilateral Integration

The delegation spent three days in Mexico City visiting universities, hospitals, research centers, and national health institutes. These meetings aimed to establish clinical validation partnerships and facilitate direct business matching with Mexican organizations developing native technology.

"Canada and Mexico are bringing their bridges closer together so companies can find commercial exchange and technological development opportunities," says Victor Sanchez, CEO of Pragmatec. "This benefits the economies of both countries and addresses relevant health problems on both sides."

Looking ahead, trade representation will expand further. In November, the Embassy of Canada and Pragmatec will organize a trade mission focused on biotechnology, pharmaceuticals, critical medicines, and active pharmaceutical ingredients.

Sanchez emphasizes that sustained engagement requires reciprocal exchange, encouraging Mexican firms, health institutions, and research centers to participate in upcoming trade missions to Ontario, Quebec, and British Columbia.